SCHEMBL20210258

SCHEMBL20210258

ClCc1ccc(CN2CCCCC2)cc1

nearest known ligand 0.82

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 5/20 0.82
HRH4 Q9H3N8 1/20 0.72
ALDH1A1 P00352 5/20 0.69
KDM4E B2RXH2 3/20 0.69
CYP2D6 P10635 1/20 0.64
CYP2C19 P33261 1/20 0.64
MBTD1 Q05BQ5 1/20 0.61
L3MBTL3 Q96JM7 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
POLB P06746 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
NCF1 P14598 1/20 0.57
MEN1 O00255 1/20 0.56
GFER P55789 1/20 0.56
KMT2A Q03164 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6057453 0.98 HRH3 (0.77) HRH3HRH4ALDH1A1KDM4ECYP2D6
Hydrochloric Acid SCHEMBL2334519 0.95 HRH3 (0.74) HRH3HRH4ALDH1A1KDM4ECYP2D6
SCHEMBL20210246 0.93 HRH3 (0.70) HRH3HRH4ALDH1A1KDM4ECYP2D6
SCHEMBL4277270 0.91 HRH3 (1.00) HRH3HRH4ALDH1A1KDM4ECYP2D6
Hydrochloric Acid SCHEMBL7468055 0.88 HRH3 (0.95) HRH3HRH4ALDH1A1KDM4ECYP2D6
SCHEMBL11201497 0.88 HRH3 (0.94) HRH3HRH4ALDH1A1KDM4ECYP2D6
Hydrochloric Acid SCHEMBL11196296 0.85 HRH3 (0.90) HRH3HRH4ALDH1A1KDM4ECYP2D6
SCHEMBL20209847 0.82 PRMT6 (0.66) HRH3HRH4ALDH1A1KDM4ECYP2D6
SCHEMBL1276590 0.82 ALDH1A1 (1.00) HRH3HRH4ALDH1A1KDM4ECYP2D6
SCHEMBL11227514 0.82 ALDH1A1 (1.00) HRH3HRH4ALDH1A1KDM4ECYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210380593-A1 PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF JIANGSU HENGRUI MEDICINE CO (CN) 2021-12-09 US disclosed
US-11117898-B2 Pyrazolo-heteroaryl derivative, preparation method and medical use thereof JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2021-09-14 US disclosed
EP-3546457-B1 PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF JIANGSU HENGRUI MEDICINE CO (CN) 2021-07-14 EP disclosed
US-20210115046-A1 PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2021-04-22 US disclosed
EP-3546457-A1 PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF Jiangsu Hengrui Medicine Co., Ltd. (CN) 2019-10-02 EP disclosed
CN-108884092-A Pyrazolo-heteroaryl analog derivative, preparation method and its application in medicine 江苏恒瑞医药股份有限公司 2018-11-23 CN disclosed
WO-2018095426-A1 PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF 江苏恒瑞医药股份有限公司 2018-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115046-A1 PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF TLR7, TLR3, TLR4 HRH3 157/4885HRH4 94/4885ALDH1A1 1071/4885
US-11117898-B2 Pyrazolo-heteroaryl derivative, preparation method and medical use thereof TLR7, TLR3, TLR4 HRH3 157/4885HRH4 94/4885ALDH1A1 1071/4885
US-20210380593-A1 PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF TLR7, TLR3, TLR4 HRH3 157/4885HRH4 94/4885ALDH1A1 1071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.